Supplement: Immunometabolic and epigenetic effects of obesity on innate immune surveillance in cancer
Supplement: Immunometabolic and epigenetic effects of obesity on innate immune surveillance in cancer
批准号:
10211421
负责人:
Lydia Lynch
金额:
$44.75万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-08-28 至 2022-07-31
关键词:
AffectAgeBostonCD8-Positive T-LymphocytesCOVID-19COVID-19 pandemicCellsCellular Metabolic ProcessCenters for Disease Control and Prevention (U.S.)Cessation of lifeChronicCollaborationsColorCommunicable DiseasesContractsCoupledCritical CareCritical IllnessDangerousnessDataDefectDiabetes MellitusDiagnosisDiseaseDisease OutbreaksElderlyEndocrineEndocrinologistEpigenetic ProcessFlow CytometryFunctional disorderFutureGrantHeart AbnormalitiesHospitalsHumanImmuneImmune responseImmune systemImmunologic SurveillanceImmunologicsImpairmentIndividualInfectionInflammationInfluenza A Virus, H1N1 SubtypeLeadLegal patentLettersLungMalignant NeoplasmsMeasuresMedical centerMetabolicMonitorMorbidity - disease rateMusNatural Killer CellsNon-Insulin-Dependent Diabetes MellitusObesityObesity associated diseaseParentsPathogenesisPathologyPatientsPhenotypePlasmaPlayPopulationPositioning AttributePredisposing FactorPredispositionProductionPublishingReportingResearchResearch PersonnelRiskRoleSample SizeSamplingSerumSevere Acute Respiratory SyndromeSeveritiesSeverity of illnessSpecialistSymptomsT cell responseT-LymphocyteTherapeuticThinnessTimeUnited States National Institutes of HealthViralVirusVirus DiseasesWomanbasebiobankcheckpoint receptorschemokinecohortcytokinecytokine release syndromecytotoxicitydesigneffective therapyfallsinnovationmetabolomicsmortalitymortality risknovelnovel strategiespandemic diseaseparent grantpatient populationperipheral bloodpreventresponseseasonal influenzasynergismtherapeutic biomarkertherapeutic targettumor
中文摘要
项目摘要
新冠肺炎大流行已经影响了全球数百万人,然而很明显,
导致危重疾病和死亡的易感因素,包括年龄较大和潜在的
情况,特别是2型糖尿病(T2 DM)和肥胖。美国疾病控制和预防中心
疾病预防控制中心(CDC)报告称,T2 DM患者的死亡风险可能高达10倍
当他们感染新冠肺炎的时候。了解免疫反应对于预防或减少
新冠肺炎的死亡率和这一患者群体的治疗策略。整体而言
这项建议的目的是确定疾病严重性和死亡增加的免疫基础。
新冠肺炎在肥胖症和2型糖尿病患者中的应用
现在人们认识到肥胖与免疫失调有关,这可能是肥胖的原因
一些与肥胖相关的疾病。例如,自然杀伤(NK)细胞,之所以被称为自然杀伤细胞,是因为它们的天然
对病毒和肿瘤的细胞毒性,无法在肥胖的人类和小鼠身上有效地杀死靶点。
我们最近在肥胖和T2 DM患者中也发现了类似的CD8T细胞缺陷。钥匙
悬而未决的问题是1)这些免疫缺陷是否导致严重程度的增加
肥胖和T2 DM患者死于新冠肺炎
对新冠肺炎的反应是不活跃还是过度活跃(破坏性的细胞因子风暴)?3)是新陈代谢
监管失调是这些缺陷的核心吗?了解这种疾病的免疫基础是至关重要的。
易感性,以预防或减少新冠肺炎的死亡率,并提供治疗策略
在这些患者群体中。这项研究的发现可能有助于理解免疫反应。
肥胖症患者未来新的病毒爆发。
英文摘要
Project Summary
The COVID-19 pandemic has affected millions worldwide, however it is clear that there are
predisposing factors that lead to critical illness and mortality including older age, and underlying
conditions particularly type 2 diabetes (T2DM) and obesity. The Centers for Disease Control and
Prevention (CDC) has reported that patients with T2DM may have up to ten-times greater risk of death
when they contract COVID-19. Understanding the immune response is critical to preventing or reducing
mortality from COVID-19 and informing therapeutic strategies for this patient population. The overall
aim of this proposal is to identify the immune basis for increased disease severity and death from
COVID-19 in patients with obesity and T2DM.
It is now appreciated that obesity is associated with immune dysregulation, which may be the cause of
some obesity related diseases. For example, Natural killer (NK) cells, so-called due to their natural
cytotoxicity against viruses and tumors, are unable to kill targets efficiently in obese humans and mice.
We have recently found similar defects in CD8 T cells in patients with obesity and T2DM. The key
unanswered questions are 1) are these immune defects responsible for the increased severity and
death from COVID-19 in patients with obesity and T2DM 2) do patents with obesity and T2DM have an
underactive or overactive (damaging cytokine storm) in response to COVID-19? and 3) is metabolic
dysregulation at the heart of these defects? It is critical to understand the immune basis for this
susceptibility in order to prevent or reduce mortality from COVID-19 and to inform therapeutic strategies
in this patient populations. Findings from this study may lead to understanding the immune response
in patients with obesity for future novel viral outbreaks.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Immunometabolic and epigenetic effects of obesity on innate immune surveillance in cancer
-
批准号:10265752
-
项目类别:
-
资助金额:$43.35万
-
财政年份:2020
-
负责人:Lydia Lynch
-
依托单位:
Immunometabolic and epigenetic effects of obesity on innate immune surveillance in cancer
-
批准号:10219918
-
项目类别:
-
资助金额:$40.7万
-
财政年份:2018
-
负责人:Lydia Lynch
-
依托单位:
Immunometabolic and epigenetic effects of obesity on innate immune surveillance in cancer
-
批准号:10459275
-
项目类别:
-
资助金额:$40.81万
-
财政年份:2018
-
负责人:Lydia Lynch
-
依托单位:
Immunometabolic and epigenetic effects of obesity on innate immune surveillance in cancer
-
批准号:9982179
-
项目类别:
-
资助金额:$40.78万
-
财政年份:2018
-
负责人:Lydia Lynch
-
依托单位:
Immunometabolic and epigenetic effects of obesity on innate immune surveillance in cancer
-
批准号:9763428
-
项目类别:
-
资助金额:$40.85万
-
财政年份:2018
-
负责人:Lydia Lynch
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
-
批准号:82505677
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:吕雨霏
-
依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
-
批准号:82574874
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:刘天华
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位: